TFAM and diabetic kidney disease: Consistently, inhibition of AMPK or Sirt1 or downregulation of PGC-1α with a siRNA significantly reduced ATP production and downregulated the expression of mitochondrial biogenesis markers such as Nrf-1 and mitochondrial factor A (TFAM) in a mouse model of diabetic nephropathy.